Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Prevention of Contrast-Induced Nephropathy
NCT00770796Phase 4Completed
- Sponsor
- Ospedale Misericordia e Dolce
- Start
- Apr 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of atorvastatin in contrast-induced nephropathy (CIN), sponsored by Ospedale Misericordia e Dolce. Started Apr 2006; status: completed.
02
Drugs
atorvastatin
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00770796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770796.